Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Hepion Pharmaceuticals Inc
HEPACurrent price
0.29 USD
-0.0031 USD (-1.07%)
Last closed
0.28 USD
Company
www.hepionpharma.com
ISIN
US4268971045
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
3 182 837 USD
Yield for 12 month
-99.58 %
1Y
3Y
5Y
10Y
15Y
HEPA
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-67 131 USD
Last Year
-67 131 USD
Current Quarter
–
Last Quarter
–
Key Figures HEPA
1 year
3 years
5 years
10 years
EBITDA
-19 315 820 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-122.71 %
PEG Ratio
–
Return On Equity TTM
-487.03 %
Wall Street Target Price
30.00 USD
Revenue TTM
–
Book Value
-25.57 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-5 519.77 USD
Diluted Eps TTM
-5 519.77 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics HEPA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History HEPA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:50
Payout Ratio TTM
–
Last Split Date
18.03.2025
Stock Valuation HEPA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.096
Price Book MRQ
2.11
Financials HEPA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HEPA
For 52 weeks
0.25 USD
79.50 USD
50 Day MA
3.07 USD
Shares Short Prior Month
7 979 511
200 Day MA
24.32 USD
Short Ratio
0.10
Shares Short
199 814
Short Percent
18.50 %
BeatStart